Teladoc faces intense competition in the telehealth services market. One of its former growth drivers is losing paying users.

In recent days, Teladoc Health has drawn attention as ongoing competitive pressure, weakness in its BetterHelp mental health ...

Chief technology officers, at vendors and providers alike, should stay close to the builders and end users, work with ...

Discover the top 3 undervalued Health Care Technology stocks for Wednesday, January 07 based on AAII’s Stock Grades.

Treasury Secretary Scott Bessent says the U.S. has more than enough funds to cover any refunds if the Supreme Court rules ...

NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, will participate in ...

HIMS expands into Canada and the U.K. while revenue and subscribers grow. However, margins and execution raise concerns.

BofA lowered the firm’s price target on Teladoc (TDOC) to $7.50 from $8 and keeps a Neutral rating on the shares. Heading into 2026, the firm ...

Hims & Hers Health, Inc. is rated a Buy with strong subscriber growth and rising revenue per subscriber. Learn more about ...

Online Dermatology Consultation Market to reach to US$ 9.2 Bn by 2035, driven by Growing Need for Convenient and Accessible ...

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued ...

Detailed price information for Dentsply Sirona Inc (XRAY-Q) from The Globe and Mail including charting and trades.